CytomX Therapeutics
CTMX
CTMX
179 hedge funds and large institutions have $908M invested in CytomX Therapeutics in 2026 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 59 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
48% more funds holding
Funds holding: 121 → 179 (+58)
28.49% more ownership
Funds ownership: 85.02% → 113.5% (+28%)
5% more call options, than puts
Call options by funds: $13.3M | Put options by funds: $12.7M
Holders
179
Holding in Top 10
3
Calls
$13.3M
Puts
$12.7M
Top Buyers
| 1 | +$47.3M | |
| 2 | +$36.9M | |
| 3 | +$30.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$25.7M |
| 5 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$22.6M |
Top Sellers
| 1 | -$32.8M | |
| 2 | -$28.3M | |
| 3 | -$16.3M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$15.9M |
| 5 |
O
OrbiMed
New York
|
-$15M |
